Sherbrooke Park Advisers’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-27,221
Closed -$165K 682
2025
Q2
$165K Buy
+27,221
New +$204K 0.07% 419
2024
Q4
Sell
-27,582
Closed -$461K 1080
2024
Q3
$461K Buy
+27,582
New +$593K 0.11% 338

Other funds holding PRTA

Sherbrooke Park Advisers's PRTA Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Prothena Corp (PRTA) in Q3 2025, closing a stake of 27,221 shares — an estimated $165K sold.

Sherbrooke Park Advisers first reported a position in PRTA in Q3 2024 and held it in 2 quarters. The position peaked at $461K in Q3 2024. 187 funds tracked by Wall St. Rank hold PRTA as of Q3 2025.

  • Sherbrooke Park Advisers reported no remaining Prothena Corp position as of Q3 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 27,221 Prothena Corp shares in Q3 2025, an estimated $165K.
  • Sherbrooke Park Advisers first reported a position in Prothena Corp in Q3 2024 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Prothena Corp position peaked at $461K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.